Compound Detail

CHEMBL402638

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

Cc1ccc2cccc(NS(=O)(=O)c3cccc([N+](=O)[O-])c3)c2n1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL402638
Phase	Preclinical
Structure Type	MOL
InChI Key	CGNPJXAKYVYRST-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

343.4

MW (Da)

3.25

ALogP

HBA

HBD

102.2

PSA (Å²)

0.58

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 3 meas. best 6.05

EC50 2 meas. best 5.22

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
Transcription factor p65 CHEMBL5533	IC50	6.05	6.05	900.0	1
Unchecked CHEMBL612545	IC50	6.05	6.025	900.0	2
NF-kappa-B inhibitor alpha CHEMBL2898	EC50	5.22	5.055	6000.0	2

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
Transcription factor p65	IC50	=	900.0	nM	6.05	Inhibition of TNF-alpha-stimulated human NF-kappaB p65 RelA subunit nuclear tran...	18024113
Unchecked	IC50	=	900.0	nM	6.05	Inhibition of NF-kappaB activation	19726185
Unchecked	IC50	=	1000.0	nM	6.0	Inhibition of TNFalpha stimulated human NF-kappaB-mediated beta lactamase gene e...	18024113
NF-kappa-B inhibitor alpha	EC50	=	6000.0	nM	5.22	Induction of human IkappaBalpha stabilization in OCI-Ly3 cells by green light em...	18024113
NF-kappa-B inhibitor alpha	EC50	=	13000.0	nM	4.89	Induction of human IkappaBalpha stabilization in OCI-Ly3 cells assessed as ratio...	18024113

PubMed	DOI	Target Context	# Activities
18024113	10.1016/j.bmcl.2007.10.100	NF-kappa-B inhibitor alpha	3
18024113	10.1016/j.bmcl.2007.10.100	Transcription factor p65	2
18024113	10.1016/j.bmcl.2007.10.100	Unchecked	1
18024113	10.1016/j.bmcl.2007.10.100	NON-PROTEIN TARGET	1
19726185	10.1016/j.bmcl.2009.08.021	Unchecked	1

Data from ChEMBL 36 via Core Engine